Download
s13005-020-00232-4.pdf 6,47MB
WeightNameValue
1000 Titel
  • Simvastatin induces adverse effects on proliferation and mineralization of human primary osteoblasts
1000 Autor/in
  1. Sabandal, Martin |
  2. Schäfer, Edgar |
  3. Aed, Jonathan |
  4. Jung, Susanne |
  5. Kleinheinz, Johannes |
  6. Sielker, Sonja |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-08-20
1000 Erschienen in
1000 Quellenangabe
  • 16(1):18
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13005-020-00232-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439668/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Frequently statins were administered to reduce the LDL-concentration in circulating blood. Especially simvastatin (SV) is an often prescribed statin. Pleiotropic effects of these drugs were reported. Thus, the aim of this study was to evaluate effects of SV on osteoblastic mineralization.!##!Methods!#!After informed consent primary osteoblasts were collected from tissue surplus after treatment of 14 individuals in the Department of Cranio-Maxillofacial Surgery, University Hospital Münster. The cells were passaged according to established protocols. Viability, mineralization capability and osteoblastic marker (alkaline phosphatase) were determined at day 9, 13 and 16 after adding various SV concentrations (0.05 μM, 0.1 μM, 0.5 μM, 1.0 μM). Statistical analysis was performed using the Kruskal-Wallis-test.!##!Results!#!The cell cultures showed a time and dose-dependent significantly decreased viability (p < 0.01) and a significantly increased mineralization (p < 0.01) in a late mineralization stage after adding SV. The typical alteration of the alkaline phosphatase (ALP) levels during osteogenic differentiation was not recognizable.!##!Conclusions!#!The pleiotropic effects found for different SV concentrations were possibly originated from other mineralization pathways beside the ALP induced one. Additionally, possible alterations of protein expression levels during mineralization and investigation of possible deviating application of SV in other treatment fields can be considered after gaining a deeper insight in the affected mechanisms.
1000 Sacherschließung
lokal Osteogenesis/drug effects [MeSH]
lokal Female [MeSH]
lokal Cell Proliferation [MeSH]
lokal Adverse effects
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Cell Differentiation [MeSH]
lokal Anticholesteremic Agents/adverse effects [MeSH]
lokal Simvastatin/adverse effects [MeSH]
lokal Osteoblasts
lokal Mineralization
lokal Male [MeSH]
lokal Simvastatin
lokal Research
lokal Osteoblasts/drug effects [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-6761-9535|https://frl.publisso.de/adhoc/uri/U2Now6RmZXIsIEVkZ2Fy|https://frl.publisso.de/adhoc/uri/QWVkLCBKb25hdGhhbg==|https://frl.publisso.de/adhoc/uri/SnVuZywgU3VzYW5uZQ==|https://frl.publisso.de/adhoc/uri/S2xlaW5oZWlueiwgSm9oYW5uZXM=|https://frl.publisso.de/adhoc/uri/U2llbGtlciwgU29uamE=
1000 Hinweis
  • DeepGreen-ID: 7015043a13e2426d87480af565f8eadd ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6466172.rdf
1000 Erstellt am 2023-11-16T19:10:58.969+0100
1000 Erstellt von 322
1000 beschreibt frl:6466172
1000 Zuletzt bearbeitet Fri Dec 01 03:47:34 CET 2023
1000 Objekt bearb. Fri Dec 01 03:47:34 CET 2023
1000 Vgl. frl:6466172
1000 Oai Id
  1. oai:frl.publisso.de:frl:6466172 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source